Acurx Pharmaceuticals, Inc.

Acurx Pharmaceuticals, Inc.verified

ACXP

Price:

$1.57

Market Cap:

$2.49M

Acurx Pharmaceuticals, Inc. functions as a clinical-stage biopharmaceutical firm focused on developing innovative antibiotic treatments for bacterial infections. The company's primary drug candidate is ibezapolstat, an antibiotic that utilizes a novel mechanism of action by targeting the polymerase IIIC enzyme. Ibezapolstat has successfully completed Phase II clinical trials for addressing Clostridium difficile infections. Additionally, Acurx is progressing with ACX-375C, an investigational therapeutic suitable for both oral and injectable administration. This compound is being developed to combat various gram-positive bacteria, including resistant strains such as methicillin-resistant Staph...[Read more]

Industry

Biotechnology

IPO Date

2021-06-25

Stock Exchange

NASDAQ

Ticker

ACXP

The Enterprise Value as of June 2026 (TTM) for Acurx Pharmaceuticals, Inc. (ACXP) is -6766398.00

According to Acurx Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -6766398.00. This represents a change of -99.64% compared to the average of -1887223180.26 of the last 4 quarters.

Acurx Pharmaceuticals, Inc. (ACXP) Historical Enterprise Value (quarterly & annually)

How has ACXP Enterprise Value performed in the past?

The mean historical Enterprise Value of Acurx Pharmaceuticals, Inc. over the last ten years is -1043455725.71. The current -6766398.00 Enterprise Value has changed -35.15% with respect to the historical average. Over the past ten years (40 quarters), ACXP's Enterprise Value was at its highest in in the March 2021 quarter at 72.72M. The Enterprise Value was at its lowest in in the December 2025 quarter at -7552367490.00.

Quarterly (TTM)
Annual

Average

-1043455725.71

Median

33.94M

Minimum

-7552367490.00

Maximum

75.13M

Acurx Pharmaceuticals, Inc. (ACXP) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Acurx Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 32.48%

Maximum Annual Enterprise Value = 75.13M

Minimum Annual Increase = -74459.79%

Minimum Annual Enterprise Value = -7552367490.00

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2025-7552367490.00-74459.79%
202410.16M-75.26%
202341.06M20.99%
202233.94M8.81%
202131.19M-58.48%
202075.13M32.48%

Acurx Pharmaceuticals, Inc. (ACXP) Average Enterprise Value

How has ACXP Enterprise Value performed in the past?

The current Enterprise Value of Acurx Pharmaceuticals, Inc. (ACXP) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-2500383799.00

5-year avg

-1487205174.00

10-year avg

-1043455725.71

Acurx Pharmaceuticals, Inc. (ACXP) Enterprise Value vs. Peers

How is ACXP’s Enterprise Value compared to its peers?

Acurx Pharmaceuticals, Inc.’s Enterprise Value is greater than Aprea Therapeutics, Inc. (-42010310.00), less than Adial Pharmaceuticals, Inc. (-1724361.00), less than BioCardia, Inc. (4.56M), less than HCW Biologics Inc. (8.02M), less than Galecto, Inc. (747.52M), less than Creative Medical Technology Holdings, Inc. (-123148.00), less than Kiora Pharmaceuticals, Inc. (719.67K), greater than IN8bio, Inc. (-12958522.00), less than Aptevo Therapeutics Inc. (8.24M), less than Brainstorm Cell Therapeutics Inc. (9.75M),

Build a custom stock screener for Acurx Pharmaceuticals, Inc. (ACXP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Acurx Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Acurx Pharmaceuticals, Inc. (ACXP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Acurx Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Acurx Pharmaceuticals, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Acurx Pharmaceuticals, Inc. (ACXP)?

What is the 3-year average Enterprise Value for Acurx Pharmaceuticals, Inc. (ACXP)?

What is the 5-year average Enterprise Value for Acurx Pharmaceuticals, Inc. (ACXP)?

How does the current Enterprise Value for Acurx Pharmaceuticals, Inc. (ACXP) compare to its historical average?